APGE position history
The shares of Apogee Therapeutics (APGE) that SOROS FUND MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 564,500 shares, $75M, 0.92% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|